Active Ingredient(s):Alosetron FDA Approved: * February 9, 2000 Pharm Company: *GLAXOSMITHKLINE Category:Irritable Bowel Syndrome
Alosetron, sold under the brand name Lotronex among others, is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only.
It was patented in 1987 and approved for medical use in 2002. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002...
* May have multiple approval dates, manufacturers, or labelers.